Position in GRAL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$15,614,388
+$9,834,154 QoQ
Shares Held
302,136
+347.4% QoQ
Ownership
0.704%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,091,323,236 across 40 Diagnostics & Research names. GRAL ranks #16 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
572,177 | $281,242,158 | |
| 2 | DHR |
Danaher Corp /De/
|
678,828 | $128,705,787 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
93,153 | $117,484,563 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
120,283 | $67,585,814 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
368,674 | $62,873,662 | |
| 6 | DGX |
Quest Diagnostics Inc
|
287,123 | $56,270,364 | |
| 7 | QGEN |
Qiagen N.V.
|
1,385,111 | $55,459,843 | |
| 8 | ILMN |
Illumina, Inc.
|
414,482 | $51,089,050 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,614,388 | 302,136 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,780,234 | 67,534 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,938,227 | 49,691 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $3,324,507 | 64,654 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,619,407 | 102,561 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $764,907 | 42,852 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $118,430 | 8,607 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $474,500 | 30,872 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||